Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Up 161.3% in December

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 8,100 shares, an increase of 161.3% from the November 30th total of 3,100 shares. Based on an average daily volume of 6,400 shares, the short-interest ratio is presently 1.3 days.

Lexaria Bioscience Stock Performance

Shares of NASDAQ LEXXW remained flat at $0.81 during trading on Friday. The business’s 50-day simple moving average is $0.77 and its 200 day simple moving average is $0.99. Lexaria Bioscience has a 1 year low of $0.33 and a 1 year high of $2.50.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.